发明授权
- 专利标题: Tetrahydrocyclopenta[b]indole androgen receptor modulators
- 专利标题(中): 四氢环戊二烯并[b]吲哚雄激素受体调节剂
-
申请号: US12989959申请日: 2009-05-14
-
公开(公告)号: US08486943B2公开(公告)日: 2013-07-16
- 发明人: Prabhakar Kondaji Jadhav , Venkatesh Krishnan , Euibong Jemes Kim
- 申请人: Prabhakar Kondaji Jadhav , Venkatesh Krishnan , Euibong Jemes Kim
- 申请人地址: US IN Indianapolis
- 专利权人: Eli Lilly and Company
- 当前专利权人: Eli Lilly and Company
- 当前专利权人地址: US IN Indianapolis
- 代理商 Elizabeth A. Dingess-Hammond; Alexander Wilson
- 国际申请: PCT/US2009/043875 WO 20090514
- 国际公布: WO2009/140448 WO 20091119
- 主分类号: A61K31/403
- IPC分类号: A61K31/403 ; C07D209/60
摘要:
The present invention provides a compound of the Formula (I), or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising a compound of Formula (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating or preventing physiological disorders, particularly reduced bone mass, osteoporosis, osteopenia, reduced muscle mass or strength, or erectile dysfunction comprising administering a compound of Formula (I), or a pharmaceutically acceptable salt thereof.
公开/授权文献
信息查询